Robert E. Gagnon - Net Worth and Insider Trading

Robert E. Gagnon Net Worth

The estimated net worth of Robert E. Gagnon is at least $3 Million dollars as of 2026-08-10. Robert E. Gagnon is the CFO of Opus Genetics Inc and owns about 584,375 shares of Opus Genetics Inc (IRD) stock worth over $2 Million. Robert E. Gagnon is the Vice President, Finance of Biogen Inc and owns about 3,999 shares of Biogen Inc (BIIB) stock worth over $828,313. Robert E. Gagnon is also the Director of Verastem Inc and owns about 41,678 shares of Verastem Inc (VSTM) stock worth over $282,994. Besides these, Robert E. Gagnon also holds Harvard Bioscience Inc (HBIO) . Details can be seen in Robert E. Gagnon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert E. Gagnon has not made any transactions after 2026-07-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Robert E. Gagnon

To

Robert E. Gagnon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert E. Gagnon owns 7 companies in total, including Verastem Inc (VSTM) , Harvard Bioscience Inc (HBIO) , and Clean Harbors Inc (CLH) among others .

Click here to see the complete history of Robert E. Gagnon’s form 4 insider trades.

Insider Ownership Summary of Robert E. Gagnon

Ticker Company Transaction Date Type of Owner
VSTM Verastem Inc 2025-12-16 Chief Financial Officer
HBIO Harvard Bioscience Inc 2018-08-29 director
CLH Clean Harbors Inc 2012-08-20 EVP CFO and Treasurer
LIMIT LIMIT 2012-02-29 Chief Acct Officer VP & Contol
LIMIT LIMIT 2024-01-08 director
LIMIT LIMIT 2026-07-23 Chief Financial Officer
LIMIT LIMIT 2026-03-18 director

Robert E. Gagnon Latest Holdings Summary

Robert E. Gagnon currently owns a total of 4 stocks. Among these stocks, Robert E. Gagnon owns 584,375 shares of Opus Genetics Inc (IRD) as of July 23, 2026, with a value of $2 Million and a weighting of 61.89%. Robert E. Gagnon owns 3,999 shares of Biogen Inc (BIIB) as of February 29, 2012, with a value of $828,313 and a weighting of 23.97%. Robert E. Gagnon also owns 41,678 shares of Verastem Inc (VSTM) as of December 16, 2025, with a value of $282,994 and a weighting of 8.19%. The other 1 stocks Harvard Bioscience Inc (HBIO) have a combined weighting of 5.96% among all his current holdings.

Latest Holdings of Robert E. Gagnon

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IRD Opus Genetics Inc 2026-07-23 584,375 3.66 2,138,813
BIIB Biogen Inc 2012-02-29 3,999 207.13 828,313
VSTM Verastem Inc 2025-12-16 41,678 6.79 282,994
HBIO Harvard Bioscience Inc 2018-08-29 32,117 6.41 205,870

Holding Weightings of Robert E. Gagnon


Robert E. Gagnon Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 2 transactions in Opus Genetics Inc (IRD) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Opus Genetics Inc is the sale of 7,783 shares on July 23, 2026, which brought Robert E. Gagnon around $22,960.

According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 1,552 shares on February 29, 2012, which brought Robert E. Gagnon around $178,868.

According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 20 transactions in Verastem Inc (VSTM) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Verastem Inc is the sale of 283 shares on December 16, 2025, which brought Robert E. Gagnon around $2,587.

More details on Robert E. Gagnon's insider transactions can be found in the Insider Trading History of Robert E. Gagnon table.

Insider Trading History of Robert E. Gagnon

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert E. Gagnon Trading Performance

GuruFocus tracks the stock performance after each of Robert E. Gagnon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert E. Gagnon is 10.52%. GuruFocus also compares Robert E. Gagnon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert E. Gagnon within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert E. Gagnon's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert E. Gagnon

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.23 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.53 LIMIT LIMIT LIMIT LIMIT LIMIT

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Robert E. Gagnon owns.
View IRD Analysis

Robert E. Gagnon Ownership Network

Ownership Network List of Robert E. Gagnon

No Data

Ownership Network Relation of Robert E. Gagnon

Insider Network Chart


Robert E. Gagnon Owned Company Details

What does Verastem Inc do?

Who are the key executives at Verastem Inc?

Robert E. Gagnon is the Chief Financial Officer of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and Chief Operating Officer Matthew Ros .

Verastem Inc (VSTM) Insider Trades Summary

Over the past 18 months, Robert E. Gagnon made 4 insider transaction in Verastem Inc (VSTM) with a net sale of 1,132. Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 145,568 shares made by Dan Paterson , a net sale of 24,659 shares made by Daniel Calkins , and a net sale of 2,366 shares made by Brian M Stuglik .

In summary, during the past 3 months, insiders sold 26,262 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 26,262 shares. During the past 18 months, 196,858 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,858 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Verastem Inc Insider Transactions

No Available Data

Robert E. Gagnon Mailing Address

Above is the net worth, insider trading, and ownership report for Robert E. Gagnon. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert E. Gagnon's mailing address is: Needham Ma 02494.